Chief Executive Officer – Dr Karmani Chetty
Dr Chetty has wide experience and expertise relevant to the requirements of a CEO of the NHLS. She is a medical doctor and Specialist in Public Health Medicine and has a Masters in Urban and Regional Planning. She has over 30 years’ experience in the healthcare environment, of which over 20 years have been in senior management and executive positions. She has been an HoD of a provincial health department, and a Deputy Director-General at both provincial and national levels, as well as having had some private sector experience. Dr Chetty’s strengths include public health sector leadership, corporate governance, strategic planning, operational implementation, financial management, health economics, human resources planning, training and development, health information, supply chain management, and research.
Executive Manager: Academic Affairs, Research & Quality Assurance – Prof Koleka Mlisana
Professor Koleka Mlisana is the Executive Manager: Academic Affairs, Research & Quality Assurance at the NHLS, since July 2018. Prior to this she was the HOD Medical Microbiology at UKZN/IALCH; and also served a term as a member of the NHLS Board. Her previous contributions include being a co-investigator and Project Director of the CAPRISA 004 tenofovir gel trial at the eThekwini site and Head of HIV Pathogenesis and Vaccine Research Programme at the Centre for the AIDS Program of Research in South Africa (CAPRISA). She has undertaken seminal research which has revealed how the body responds during acute HIV infection. She was the Protocol co-Chair and Project Director of the CAPRISA 002 study, a >10 year follow-up study of patients with acute HIV infection. Her current research interests include TB diagnostics, drug resistance as well as Sexually Transmitted Infections and has co-authored more than 130 peer reviewed journal articles. She has been a member of the Board of the South African Medical Research Council and currently serves on the Ministerial Advisory Committee on Antimicrobial Resistance and is a member of the Board of Trustees for the South African National AIDS Council.
Mr Hlongwane holds a Master of Business and a Master of Technology in Business Information Systems.
Mr Hlongwane joins the NHLS from the position of Director of Information Technology Service Management in the Gauteng Department of Education, where he also acted as Chief Director. Prior to this he was IT Support / Delivery Service Manager at IBM / Masana Consortium.
Chief Financial Officer – Michael Sass
Mr Sass is a Chartered Accountant and Certified Internal Auditor and holds a Master’s Degree in Commerce.
Mr Sass has vital private and public sector experience and know-how for his role in the NHLS. Prior to joining the NHLS, Mr Sass was the Deputy Director-General in the Gauteng Provincial Government and Accountant General in the National Treasury. He was also CFO at Verimark, and a Director at Morvest, Business Innovation Group (BIG) and Grant Thornton.
Interim Executive Director NICD – Prof Adrien Puren
Prof Puren is the newly appointed Acting Executive Director of the NICD since December 2020. Prof Adrian Puren was trained and held a lectureship at the University of the Witwatersrand, before taking on various positions at the NICD. Adrian was appointed as Deputy Director and Head of Virology in 1999 and Head of the Centre for HIV and STIs in 2017. As head of virology, he focused on developing and implementing a range of viral diagnostic platforms in support of the NICD’s EPI surveillance programmes and diagnostic support.
Adrian’s main interest is in the development of HIV surveillance programmes with a particular focus on HIV incidence and the use of “big data” to inform surveillance, monitoring and evaluation. Prof Puren heads the regional and national endpoint diagnostics laboratory for HVTN-supported vaccine and antibody-mediated preventions trials. He serves as the quality assurance technical manager for the NICD and in this capacity, he has provided support to the National Department of Health’s implementation and quality assurance of HIV rapid testing. Prof Puren serves on various expert bodies and the most recent is the South African Lancet Commission on High Quality Health in the era of Sustainable Development Goals.
Executive Director: NIOH – Dr Spo Kgalamono
Dr Kgalamono is a renowned expert in occupational medicine and regarded as one of the most influential women in occupational health in South Africa. She is presently the Executive Director for the National Institute of Occupational Health and with over 20 years’ occupational health experience under her belt, Dr Kgalamono is a joint appointee and a Senior Lecturer at the University of Witwatersrand, School of Public Health. She has co-authored several peer-reviewed journals and her main area of interest is workplace mental health. Over the years, she has received many awards including the Best Investigator Award in 2010 at the International Mesothelioma Conference in Japan, and the Golden Key Award for excellent achievement in 2010. The Public Health Association of South Africa (PHASA) in 2011 recognised her as one of the three most influential women in public health in South Africa. She also sits on several committees including the SA Society for Occupational Medicine; the International Working Group on Occupational Diseases; and the Medical Bureau for Occupational Diseases Review Authority.
Human Resources Executive: Makgopelo Mkhwanazi
Company Secretary – Adv Mpho Mphelo
Manager SAVP – Megan Saffer